Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: DIASORIN MOLECULAR, LLC
Awarding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Funding agency: Department of Health and Human Services / Office of Assistant Secretary for Preparedness and Response
Period of performance: 2022-09-30 to 2024-12-31
Current total value of award: $30954000
Description: IT IS ESTIMATED THAT JUST 5,000 US PHARMACIES OFFER POINT-OF-CARE (POC) MOLECULAR DIAGNOSTICS WITH THE OTHER 83,000 LOCATIONS ONLY OFFERING SAMPLE COLLECTION / SEND OUT SERVICES OR PROVIDING NO TESTING AT ALL. IN THIS EFFORT, LUMINEX CORPORATION, A